New knowledge about bone marrow transplants can help leukemia patients
Johan Jansson's research at Kalmar University in Sweden shows that cancer cells that have been exposed to chemotherapy and survived are less vulnerable to chemotherapy, and more aggressive as well.
But this research also yielded discoveries that should be able to enhance our treatment of the disease.
Johan Jansson's research shows that leukemia cells that have been exposed to chemotherapy and survived did not develop resistance against bone marrow transplants from a sibling, for example. At the same time, however, several important changes were observed in these cancer cells. On the one hand, they were less vulnerable to chemotherapy and, on the other, their growth rate increased.
Johan Jansson also identified several immunologically important genes that either increased or decreased when they had been exposed to a bone marrow transplant. Three of these genes were especially interesting in that they were involved in activating the immune defense and the killing of cancer cells. It was also shown that such a bone marrow transplant could have an inhibiting effect on the leukemia cells that also proved to be able to activate parts of the immune defense.
Finally, Johan Jansson studied whether it is possible to check the leukemia cells that remain after a bone marrow transplant. This was done by vaccinating mice with a mixture of 'dead' leukemia cells and immune cells from a donor. It was observed that the immune defense was activated to some degree, but that the mice did not live any longer as a result. On the other hand, it was seen that these mice had B cells that produced antibodies against leukemia cells. This knowledge could be further elaborated to develop and enhance the effects of a bone marrow transplant.
Thesis directors: Prof. Craig A. Mullen, University of Rochester, NY, USA; Prof. Sven Tågerud, Kalmar University, Sweden.
Deputy director: Prof. Kristina Nilsson Ekdahl, Kalmar University.
External examiner: Prof. Mikael Sigvardsson, Linköping University, Sweden
Johan Jansson can be reached at jo.jansson@gmail.com or phone: +1-585-719-5562 and through October 6 at cell phone: +46-73 3988792
Sven Tågerud can be reached at sven.tagerud@hik.se, phone: +46 (0)480-44 62 56.
Pressofficer Karolina Ekstrand; karolina.ekstrand@hik.se; +46-766476 030
Media Contact
More Information:
http://www.vr.seAll latest news from the category: Health and Medicine
This subject area encompasses research and studies in the field of human medicine.
Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.
Newest articles
Innovative 3D printed scaffolds offer new hope for bone healing
Researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed PLA-CaP scaffolds that promote blood vessel formation, ensuring better healing and regeneration of bone tissue. Bone is…
The surprising role of gut infection in Alzheimer’s disease
ASU- and Banner Alzheimer’s Institute-led study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral…
Molecular gardening: New enzymes discovered for protein modification pruning
How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…